1. Haloperidol, but not olanzapine, may affect expression of PER1 and CRY1 genes in human glioblastoma cell line
- Author
-
Łukasz Mokros, Andrzej Witusik, Katarzyna Nowakowska-Domagała, Tadeusz Pietras, Michał Seweryn Karbownik, Janusz Szemraj, Łukasz Wieteska, Adam Antczak, and Karol Woźniak
- Subjects
Olanzapine ,endocrine system ,Physiology ,medicine.medical_treatment ,Dopaminergic ,Pharmacology ,Biology ,030227 psychiatry ,CLOCK ,03 medical and health sciences ,0302 clinical medicine ,Real-time polymerase chain reaction ,Cell culture ,Physiology (medical) ,medicine ,Haloperidol ,Antipsychotic ,030217 neurology & neurosurgery ,Ecology, Evolution, Behavior and Systematics ,PER1 ,medicine.drug - Abstract
Background: There is barely any evidence of antipsychotic drugs affecting the molecular clockwork in human, yet it is suggested that clock genes are associated with dopaminergic transmission, i.e. the main target of this therapeutics. We decided to verify if haloperidol and olanzapine affect expression of CLOCK, BMAL1, PER1 and CRY1 in a human central nervous system cell line model. Methods: U-87MG human glioblastoma cell line was used as an experimental model. The cells were incubated with or without haloperidol and olanzapine in the concentration of 5 and 20 μM for 24 h. Real-time quantitative polymerase chain reaction with the ΔCT analysis was used to examine the effect of haloperidol and olanzapine on the mRNA expression of the genes. Results: At 5 μM, haloperidol decreased expression of CRY1 almost 20-fold. There was nearly a 1.5-fold increase in expression of PER1. Considering the 20 μM haloperidol concentration and both olanzapine concentrations, no other statistically significant effect wa...
- Published
- 2016
- Full Text
- View/download PDF